Tag: complex pharmaceutical formulations
Mayne Pharma to acquire a portfolio of US generic products from Teva and Allergen
ASX-listed specialty pharmaceutical company Mayne Pharma has entered into a binding agreement to acquire a portfolio of US generic products from Teva and Allergen for...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
